article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

The growing role of artificial intelligence (AI) and the importance of the “human aspect” throughout Pharma operations. After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) in person again, believing that’s what most KOLs want.

Pharma 94
article thumbnail

Pharma firepower, M&A surge last year bode well for dealmaking prospects in 2024: EY

Fierce Pharma

Morgan Healthcare Conference. | The late surge of activity in 2023 also bodes well for a 2024 uptick, the group said. Biopharma companies looking to maximize the visibility of their M&A activity often reveal deals during the J.P.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2023 Pharmacovigilance Industry Survey: Unveiling Transformation Trends

Fierce Pharma

In the dynamic realm of healthcare, ensuring drug safety stands as an absolute priority for life sciences companies. Explore the 2023 PV Industry Survey and learn about the pivotal shifts in drug safety practices, from automation to the emergence of Gen AI. Read now.

Safety 130
article thumbnail

Healthcare Watch October 2023

PM360

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. and France regarding pharma-provided digital platforms. One participant summed up these perceptions by stating “It’s a pharmaceutical site, you know.

article thumbnail

Kusum Healthcare Pvt. Ltd -Walk-In Interview for Production/ QC On 13th Feb’ 2023

Pharma Pathway

Kusum Healthcare Pvt. Ltd -Walk-In Interview for Production/ QC On 13th Feb’ 2023 Job Description Kusum Healthcare Pvt. Walk-In Interview for Production/ QC On 13th Feb’ 2023 Departments @ Kusum Healthcare Pvt. Kusum Healthcare Pvt. Ltd Departments: Production/ QC Positions: Officer/ Sr.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

article thumbnail

JP Morgan 2023 – Day 2

pharmaphorum

Fierce’s event “The long haul: How pharma and healthcare can survive in 2023” will feature guests from Bayer, Takeda, Genentech, and more. The post JP Morgan 2023 – Day 2 appeared first on. We’ll do our best to surf between the two, as well as providing remote updates where we can from the main event.